- Organizations: Johnson & Johnson
Pipeline
MeiraGTx acquires J&J's XLRP investigational therapy
Deal includes all interests in botaretigene sparoparvovec (bota-vec); company plans to immediately file for global regulatory approval.
Events
ASCRS 2026 highlights key trends in surgical ecosystem
Annual meeting of cataract and refractive surgeons kicks off in the nation’s capital with focus on developments in surgical devices and IOLs.
Products
Johnson & Johnson launches expanded parameters for ACUVUE VITA contact lenses
Monthly lens now offers ‘around the clock’ coverage across the full power range (-9.00 to +6.00) for astigmatic patients.
Products
FDA approves J&J's TECNIS PureSee IOL for cataract patients
Approval is the first extended-depth-of-focus lens with no warning on loss of contrast sensitivity; availability to follow later this year.
Business
Leadership watch: J&J and Rebion appoint new executives
Business
Leadership watch: ViaLase, J&J, Alcon, and myze make executive additions
Check out the latest leadership news from the eyecare space, including a new CEO at ViaLase and a leading optometrist joining myze.
Products
J&J launches Acuvue Oasys Max 1-Day MF contact lens for astigmatism
Newest addition to the ACUVUE brand is the first and only disposable contact lens for patients with both astigmatism and presbyopia.
Business
Johnson & Johnson names industry exec as president of Vision Care
Shawn Millerick is the new president of the Americas division, while Erin Powers is now leading as VP of the North American Surgical Vision business.
Products
J&J expands US rollout of TECNIS Odyssey IOL
Purely refractive presbyopia-correcting lens provides full visual range with minimal visual complaints and higher tolerance to residual refractive errors.
Pipeline